BRIEF-Roche Expands Indication For Cobas EGFR Mutation Test V2 As Companion Diagnostic With Tagrisso By: Reuters: Company News April 18, 2018 at 19:22 PM EDT * ROCHE EXPANDS INDICATION FOR COBAS® EGFR MUTATION TEST V2 AS A COMPANION DIAGNOSTIC WITH TAGRISSO® Read More >> Related Stocks: Astrazeneca Plc ADR Rogers Corp